BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 26221)

  • 1. Chronic cutaneous graft-versus-host disease in man.
    Shulman HM; Sale GE; Lerner KG; Barker EA; Weiden PL; Sullivan K; Gallucci B; Thomas ED; Storb R
    Am J Pathol; 1978 Jun; 91(3):545-70. PubMed ID: 26221
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical characteristics of chronic cutaneous graft-versus-host disease in Japanese leukemia patients after bone marrow transplantation: low incidence and mild manifestations of skin lesions.
    Fujii H; Hiketa T; Matsumoto Y; Ohashi M; Miyamura Y; Tanimoto M; Morishima Y; Saito H; Horibe K; Shibata Y
    Bone Marrow Transplant; 1992 Oct; 10(4):331-5. PubMed ID: 1422488
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cutaneous lichenoid graft-versus-host disease mimicking lupus erythematosus.
    Goiriz R; Peñas PF; Delgado-Jiménez Y; Fernández-Herrera J; Aragüés-Montañés M; Fraga J; García-Díez A
    Lupus; 2008 Jun; 17(6):591-5. PubMed ID: 18539715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histological evaluation of acute mucocutaneous graft-versus-host disease in nonmyeloablative hematologic stem cell transplants with an observation predicting an increased risk of progression to chronic graft-versus-host disease.
    Bridge AT; Nelson RP; Schwartz JE; Mirowski GW; Billings SD
    Am J Dermatopathol; 2007 Feb; 29(1):1-6. PubMed ID: 17284954
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Partial reconstitution of cutaneous microvessels in long-term survivors after allogeneic bone marrow transplantation.
    Haeusermann P; Kump E; Rovó A; Tichelli A; Itin P; Gratwohl A; Biedermann BC
    Dermatology; 2009; 219(1):32-41. PubMed ID: 19407437
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of related donor peripheral blood and bone marrow transplants: importance of late-onset chronic graft-versus-host disease and infections.
    Anderson D; DeFor T; Burns L; McGlave P; Miller J; Wagner J; Weisdorf D
    Biol Blood Marrow Transplant; 2003 Jan; 9(1):52-9. PubMed ID: 12533742
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Graft-versus-leukaemia activity associated with CMV-seropositive donor, post-transplant CMV infection, young donor age and chronic graft-versus-host disease in bone marrow allograft recipients. The Nordic Bone Marrow Transplantation Group.
    Jacobsen N; Badsberg JH; Lönnqvist B; Ringdén O; Volin L; Rajantie J; Nikoskelainen J; Keiding N
    Bone Marrow Transplant; 1990 Jun; 5(6):413-8. PubMed ID: 2164434
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Similarity between eruptions induced by sulfhydryl drugs and acute cutaneous graft-versus-host disease after bone marrow transplantation.
    Takatsuka H; Takemoto Y; Yamada S; Mori A; Wada H; Fujimori Y; Okamoto T; Kanamaru A; Kakishita E
    Hematology; 2002 Feb; 7(1):55-7. PubMed ID: 12171778
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Late-onset keratoconjunctivitis sicca syndrome after bone marrow transplantation: incidence and risk factors. European Group or Blood and Marrow Transplantation (EBMT) Working Party on Late Effects.
    Tichelli A; Duell T; Weiss M; Socié G; Ljungman P; Cohen A; van Lint M; Gratwohl A; Kolb HJ
    Bone Marrow Transplant; 1996 Jun; 17(6):1105-11. PubMed ID: 8807122
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gastrointestinal involvement in chronic graft-versus-host disease: a clinicopathologic study.
    Akpek G; Chinratanalab W; Lee LA; Torbenson M; Hallick JP; Anders V; Vogelsang GB
    Biol Blood Marrow Transplant; 2003 Jan; 9(1):46-51. PubMed ID: 12533741
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Skin biopsies for early diagnosis and prognosis of graft-versus-host disease in recipients of allogeneic stem cells from blood or bone marrow.
    Heldal D; Brinch L; Evensen SA; Tjønnfjord GE; Aamodt G; Elgjo K; Sviland L
    Bone Marrow Transplant; 2004 Aug; 34(4):345-50. PubMed ID: 15170163
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isomorphic cutaneous graft-versus-host disease reaction after ultraviolet exposure: clinical, histological and direct immunofluorescence studies of four allo-transplanted patients.
    Vassallo C; Brazzelli V; Zecca M; Locatelli F; Alessandrino PE; Borroni G
    J Eur Acad Dermatol Venereol; 2009 Aug; 23(8):913-8. PubMed ID: 19586515
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunohistologic and ultrastructural study of the sclerotic skin in chronic graft-versus-host disease in man.
    Janin-Mercier A; Devergie A; Van Cauwenberge D; Saurat JH; Bourges M; Lapiere CM; Gluckman E
    Am J Pathol; 1984 May; 115(2):296-306. PubMed ID: 6372497
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The skin biopsy in the diagnosis of acute graft-versus-host disease in man.
    Sale GE; Lerner KG; Barker EA; Shulman HM; Thomas ED
    Am J Pathol; 1977 Dec; 89(3):621-36. PubMed ID: 23008
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Changes in the skin in transplantation versus host reaction. 2. Our clinical findings from observations using light microscopy and electron microscopy].
    Dobrić I; Vujasinović S; Labar B; Bogdanić V; Nemet D; Kastelan A; Baricević B; Vranesić D; Skrinjar L
    Lijec Vjesn; 1989 Mar; 111(3):76-80. PubMed ID: 2747408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PUVA therapy for chronic cutaneous graft-vs-host disease.
    Jampel RM; Farmer ER; Vogelsang GB; Wingard J; Santos GW; Morison WL
    Arch Dermatol; 1991 Nov; 127(11):1673-8. PubMed ID: 1952971
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Eczematoid graft-vs-host disease: a novel form of chronic cutaneous graft-vs-host disease and its response to psoralen UV-A therapy.
    Creamer D; Martyn-Simmons CL; Osborne G; Kenyon M; Salisbury JR; Devereux S; Pagliuca A; Ho AY; Mufti GJ; du Vivier AW
    Arch Dermatol; 2007 Sep; 143(9):1157-62. PubMed ID: 17875877
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Skin manifestations of graft-versus-host reaction following bone marrow transplantation].
    Itin PH; Lautenschlager S; Orth B; Rufli T; Gratwohl A
    Schweiz Med Wochenschr; 1996 Mar; 126(9):339-47. PubMed ID: 8701251
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of cyclosporine and methylprednisolone dose used for prophylaxis and therapy of graft-versus-host disease on survival and relapse after allogeneic bone marrow transplantation.
    Michallet M; Perrin MC; Belhabri A; Molina L; Nicolini F; Tigaud JD; Sotto JJ; Guyotat D; Fière D; Archimbaud E
    Bone Marrow Transplant; 1999 Jan; 23(2):145-50. PubMed ID: 10197799
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral patterns of acute and chronic graft-v-host disease.
    Barrett AP; Bilous AM
    Arch Dermatol; 1984 Nov; 120(11):1461-5. PubMed ID: 6388506
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.